The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases

N Chalasani, Z Younossi, JE Lavine, M Charlton… - Hepatology, 2018 - journals.lww.com
This guidance provides a data‐supported approach to the diagnostic, therapeutic, and
preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. A “Guidance” document …

[HTML][HTML] Liver transplantation 2023: status report, current and future challenges

NA Terrault, C Francoz, M Berenguer… - Clinical …, 2023 - Elsevier
Liver transplantation offers live-saving therapy for patients with complications of cirrhosis
and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and …

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

M Eslam, SK Sarin, VWS Wong, JG Fan… - Hepatology …, 2020 - Springer
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

European Association for the Study of the Liver (EASL)… - Obesity Facts, 2024 - karger.com
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

ESPEN guideline on clinical nutrition in liver disease

M Plauth, W Bernal, S Dasarathy, M Merli, LD Plank… - Clinical nutrition, 2019 - Elsevier
This update of evidence-based guidelines (GL) aims to translate current evidence and
expert opinion into recommendations for multidisciplinary teams responsible for the optimal …

Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment

VWS Wong, WK Chan, S Chitturi… - Journal of …, 2018 - Wiley Online Library
Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …

NAFLD and liver transplantation: current burden and expected challenges

R Pais, AS Barritt 4th, Y Calmus, O Scatton, T Runge… - Journal of …, 2016 - Elsevier
Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic
fatty liver disease (NAFLD) is increasing both in Europe and the United States, becoming …

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by …

JI Mechanick, A Youdim, DB Jones, WT Garvey… - Surgery for Obesity and …, 2013 - Elsevier
The development of these updated guidelines was commissioned by the AACE, TOS, and
ASMBS Board of Directors and adheres to the AACE 2010 protocol for standardized …

Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes

A Ahmed, RJ Wong, SA Harrison - Clinical Gastroenterology and …, 2015 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal serum
aminotransferase levels in both developed and developing countries. Patients with …

Nonalcoholic Fatty Liver Disease (Japanese Version)

XJ Wang, H Malhi - Annals of internal medicine, 2018 - acpjournals.org
非アルコール性脂肪性肝疾患 (NAFLD) は, 慢性肝疾患の主な原因である. 多くはプライマリケアや
病院における肝酵素の上昇や脂肪肝の画像所見により, 偶発的に診断される. NAFLD …